C 
China Health Industries Holdings CHHE · USD
Consumer Staples · US listing · 🇺🇸 United States
0.00
—
Close of 30 Oct 2026, in USD
At a glance
Figures in USD, from our data supplier.
Revenue
$111,579
FY2014FY2023
Net income
−$409,000
FY2014FY2023
Free cash flow
−$42.3m
FY2014FY2023
Shareholders' equity
$39.1m
FY2014FY2023
Income statement
Fiscal years
| FY2023 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $111,579 | $6.5m | $9.9m | $9.3m | $6.6m | $6.4m | $7.8m | $10.2m | $9.7m |
| Gross profit | $220 | $3.6m | $7.3m | $7.0m | $2.3m | $2.3m | $2.3m | $2.9m | $2.4m |
| Research and development | — | — | — | — | — | — | — | — | $156,735 |
| Operating income | −$1.8m | $1.9m | $4.9m | $4.6m | −$467,000 | −$168,000 | −$281,000 | $226,739 | −$720,000 |
| Net income | −$409,000 | $1.3m | $3.6m | $3.3m | −$317,000 | $1.3m | $159,602 | $2,561 | −$658,000 |
| Diluted earnings per share | -0.01 | 0.02 | 0.05 | 0.05 | -0.00 | 0.02 | 0.00 | 0.00 | -0.01 |
Balance sheet
At each fiscal year end
| FY2023 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | $45.1m | $53.9m | $48.2m | $45.8m | $42.9m | $41.7m | $40.3m | $41.5m | $40.9m |
| Cash and short-term investments | $47,246 | $44.3m | $36.1m | $35.5m | $32.6m | $30.0m | $29.8m | $29.2m | $27.2m |
| Total liabilities | $6.0m | $9.1m | $8.6m | $8.6m | $7.7m | $7.0m | $6.0m | $5.2m | $4.8m |
| Debt | $5.2m | $8.1m | $7.3m | $7.0m | $6.4m | $5.2m | $4.2m | $3.5m | $3.4m |
| Shareholders' equity | $39.1m | $44.8m | $39.7m | $37.2m | $35.2m | $34.7m | $34.2m | $36.3m | $36.1m |
| Shares outstanding | 66m | 66m | 66m | 66m | 66m | 66m | 66m | 66m | 62m |
Cash flow
Fiscal years
| FY2023 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −$42.3m | $5.6m | $2.4m | $5.1m | $3.0m | $1.1m | $1.9m | $2.1m | −$1.4m |
| Capital spending | — | −$13,655 | −$157,800 | −$153,576 | −$407,211 | −$311,680 | −$154,077 | −$628,392 | −$137,395 |
| Free cash flow | −$42.3m | $5.5m | $2.2m | $5.0m | $2.6m | $763,340 | $1.7m | $1.5m | −$1.5m |
Latest quarters
By quarter end
| Mar 2024 | Dec 2023 | Sept 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sept 2022 | Jun 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $87 | $46 | $38,300 | $57,513 | $21,416 | $32,650 | — | −$2 |
| Gross profit | −$69,693 | — | −$94,514 | −$5,118 | $2,333 | $3,005 | −$156,000 | $12 |
| Operating income | −$142,256 | −$445,555 | −$183,957 | −$609,580 | −$329,465 | −$413,000 | −$491,000 | −$622,887 |
| Net income | −$142,752 | −$445,557 | −$182,354 | −$591,342 | −$290,288 | $929,303 | −$456,000 | $519,883 |
| Diluted earnings per share | -0.00 | -0.01 | -0.00 | -0.01 | -0.00 | 0.01 | -0.01 | 0.01 |
| Cash from operations | — | — | — | −$42.0m | — | — | — | — |
| Total assets | $4.1m | $4.3m | $44.6m | $45.1m | $48.5m | $48.5m | $47.6m | $50.7m |
| Cash and short-term investments | $18,100 | — | $12,468 | — | $43.3m | $43.2m | $42.1m | $44.8m |
| Debt | $5.5m | — | $5.2m | — | $5.8m | $5.7m | $5.6m | $6.8m |
| Shareholders' equity | −$2.4m | −$2.3m | $38.7m | $39.1m | $41.9m | $42.0m | $39.8m | $42.8m |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -77.6% | -55.7% | -34.5% |
| Operating income | — | 31.6% | 9.0% |
| Net income | — | 5.2% | -3.0% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | -1.1% | 66.0% | 62.5% | 42.0% |
| Operating margin | -3121.3% | 19.7% | 22.7% | 7.6% |
| Net margin | -682.2% | 24.7% | 21.8% | 9.9% |
Valuation history
At each fiscal year end
| FY2023 | FY2022 | FY2021 | |
|---|---|---|---|
| Price to earnings | -2.4 | -0.1 | 0.0 |
| Price to sales | 8.9 | 106.0 | — |
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | -100% | 1513% | 3849% | 54% | 6153% | 77% | -45% | 233% | 477% | 580% |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years.
- 20-to-1 reverse split · 13 Nov 2008
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.